US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 167 actively recruiting studies with Wisconsin sites out of 167 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Prostate Cancer, Colorectal Cancer. Leading sponsors running trials in the state include University of Wisconsin, Madison, Medical College of Wisconsin, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (34), Phase 2 (47), Phase 3 (43), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
167
Recruiting Now
167
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (5)Prostate Cancer (4)Colorectal Cancer (3)Solid Tumor (3)Acute Myeloid Leukemia (3)Anxiety (3)Heart Failure (3)Mantle Cell Lymphoma (MCL) (3)Healthy (2)Metastatic Castration-resistant Prostate Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Relapsing Remitting Multiple Sclerosis (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 167 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 167. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT05521698 Phase 1
Recruiting
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
80 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT07766187 Phase 2
Recruiting
Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepat...
Condition
Intrahepatic Cholangiocarcinoma
Enrollment
12 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06909214 Phase 4
Recruiting
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With...
Condition
New Onset Generalized Myasthenia Gravis (gMG)
Enrollment
30 pts
Location
United States
Sponsor
argenx
View Trial →
NCT05550298 N/A
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infectio...
Condition
Hematopoietic Cell Transplant
Enrollment
2,000 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
View Trial →
NCT06734351 Phase 3
Recruiting
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adu...
Condition
Mid Face Volume Deficit
Enrollment
231 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06445946 Phase 4
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Tr...
Condition
Gestational Diabetes Mellitus
Enrollment
1,572 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06692192 Phase 1
Recruiting
The RECAP2 Study: Midazolam and Psilocybin
Condition
Psilocybin
Enrollment
60 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05788536 Phase 1, Phase 2
Recruiting
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Childr...
Condition
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Enrollment
36 pts
Location
United States, Germany, Japan
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07446101 Phase 1
Recruiting
A Study of Mirikizumab Solution (LY3074828) in Healthy Participants
Condition
Healthy
Enrollment
450 pts
Location
United States
Sponsor
Eli Lilly and Company
View Trial →
NCT06832410 Phase 3
Recruiting
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type ...
Condition
Type 1 Diabetes
Enrollment
10 pts
Location
United States, Canada, Saudi Arabia
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07571343 N/A
Recruiting
Fueling Labor: Protein Supplementation for Intrapartum Glucose Control
Condition
Diabetes During Pregnancy
Enrollment
60 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT04186520 Phase 1, Phase 2
Recruiting
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Condition
Non Hodgkin Lymphoma (NHL)
Enrollment
100 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07437950 Phase 2
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly ...
Condition
Acute Myeloid Leukemia
Enrollment
126 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05413421 Phase 1
Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Condition
Metastatic Prostate Cancer
Enrollment
275 pts
Location
United States, Australia, Spain
Sponsor
ORIC Pharmaceuticals
View Trial →
NCT06422806 Phase 3
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone f...
Condition
Metastatic Dedifferentiated Liposarcoma
Enrollment
365 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06707493 Phase 2
Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
Condition
IDH1 Mutation
Enrollment
75 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07624747 N/A
Recruiting
Brain Health in Transgender Adults
Condition
Gender Dysphoria
Enrollment
72 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT05850234 Phase 1, Phase 2
Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
232 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT06401421 N/A
Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Brea...
Condition
Breast Cancer
Enrollment
1,800 pts
Location
United States, Canada
Sponsor
Exact Sciences Corporation
View Trial →
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
NCT07440225 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Argentina, Australia
Sponsor
EyeBiotech Ltd.
View Trial →
Page 5 of 7 — 167 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology